Pulmonx Corp 8-K Summary: May 20, 2021
Business Context and Reporting Period
This Form 8-K reports on the results of Pulmonx Corporation's 2021 Annual Meeting of Stockholders held on May 20, 2021. The company is an emerging growth company incorporated in Delaware, with its common stock (LUNG) trading on The Nasdaq Stock Market LLC.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and does not contain financial performance data.
Material Changes
No material financial changes are reported in this filing. The document details the outcomes of two shareholder proposals:
- Proposal 1 (Election of Directors): Glendon E. French was elected to serve until the 2024 Annual Meeting.
- Proposal 2 (Ratification of Auditors): The appointment of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021, was ratified.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. For a more complete description of the matters voted upon, investors are referred to the definitive proxy statement filed on April 9, 2021.
Key Facts for Investor Verification
- Director Election Results: Glendon E. French received 21,885,421 votes "For," 1,886,746 "Withheld," and 1,425,850 "Broker Non-Votes."
- Auditor Ratification Results: BDO USA, LLP received 25,163,522 votes "For," 26,890 "Against," and 7,605 "Abstentions."
- Broker Non-Votes: There were 1,425,850 broker non-votes on the director election and 0 on the auditor ratification.
- Reference Document: Detailed context regarding the proposals is located in the proxy statement filed on April 9, 2021.